Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41

Benzinga · 2d ago
Morgan Stanley analyst Joe Laetsch maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $36 to $41.